2014³âµµ NAMSA ÄÁÆÛ·±½º
1. Conference
- ÀÏ ½Ã : 2014³â 4¿ù 17ÀÏ (¸ñ) / (Àå ¼Ò : ¿µµîÆ÷ Çѱ¹ÈÇÐÀ¶ÇÕ½ÃÇ迬±¸¿ø ´ë°ÀǽÇ)
- Âü¿©Àοø : 70¿©¸í (20¸í Ãß°¡¸ðÁý) / ±³À°ºñ ¹«·á
- Á¢¼ö¹æ¹ý : www.medihrd.or.krȨÆäÀÌÁö °¡ÀÔ ÈÄ Á¢¼ö (¿Â¶óÀÎÁ¢¼ö¸¸ ¹Þ½À´Ï´Ù.)
¹® ÀÇ : ¸ÞµðÆÛÆ® ³ª¿ëÇÏ 02-921-6103, 010-7353-3773, yongha@medipert.com
¹ÚÁø¿µ 02-921-6101, jyp@medipert.co
▸ ±³À°Àå¼Ò : ¼¿ïƯº°½Ã ¿µµîÆ÷±¸ ¹öµå³ª·ç·Î 155 (¿µµîÆ÷µ¿8°¡ 88-2¹øÁö)
(Çѱ¹ÈÇÐÀ¶ÇÕ½ÃÇ迬±¸¿ø)
▸ ÁöÇÏö : 2È£¼± ´ç»ê¿ª ÇÏÂ÷ 6¹øÃⱸ µµº¸ 7ºÐ°Å¸®
9È£¼± ´ç»ê¿ª ÇÏÂ÷ 8¹øÃⱸ µµº¸ 5ºÐ°Å¸®
▸ ¹ö ½º : 5714, 605, 6514, 6619, 6623, 6633, 760, 9707
(»ï¼º·¡¹Ì¾È¾ÆÆÄÆ® ¾Õ ÇÏÂ÷)
▸±³À°±â°£ Áß ÁÖÂ÷°¡ ºÒ°¡ÇÏ¿À´Ï ´ëÁß±³ÅëÀ» ÀÌ¿ëÇÏ¿© ±³À°¿¡ Âü¼®ÇÏ¿© Áֽñ⠹ٶø´Ï´Ù.
ÁÖ °ü : NAMSA, Çѱ¹ÀÇ·á±â±â°ø¾÷Çùµ¿Á¶ÇÕ / ÁÖ ÃÖ : ¸ÞµðÆÛÆ® (NAMSA Agent in KOREA)
- ÄÁÆÛ·±½º ÁÖÁ¦ ¹× ½Ã°£Ç¥ ( ¡Ø °ÀÇ´Â ¿µ¾î·Î¸¸ ÁøÇàµË´Ï´Ù. )
ÀÏÀÚ (Date) |
½Ã°£(Time) |
³»¿ë(Agenda) |
ÁøÇà/°»ç (Moderator/Speaker) |
04/17 (¸ñ) |
10:00 – 10:50 |
Thinking Globally During Product Development |
Dr. Seth Goldenberg, Medical Research Scientist, NAMSA |
11:00 – 11:50 |
US FDA medical device regulation and product registration |
Dr. Seth Goldenberg, Medical Research Scientist, NAMSA |
|
12:00 – 13:30 |
Lunch Break |
||
13:30 – 14:20 |
Methods and interpretation of pre-clinical performance studies |
Dr. Jean-Pierre Boutrand, VP of Global Sales, NAMSA |
|
14:30 – 15:20 |
Biological evaluation and regulation of medical devices in the European Union Update on the EU Med. Dev. New Regulation in the EU |
Dr. Jean-Pierre Boutrand, VP of Global Sales, NAMSA |
|
15:30 – 16:20 |
Chinese CFDA medical device regulation and special biocompatibility requirements |
An Liu, GM of NAMSA China, NAMSA |